ST Spring has disclosed its earnings forecast, expecting a net loss attributable to the parent of 32.28 million to 37.52 million yuan in the first half of 2026, compared with a profit of 1.317 million yuan in the same period last year. The net loss after deducting non-recurring items is expected to be 34.55 million to 39.79 million yuan, compared with a loss of 1.7877 million yuan in the same period last year. The company's main business includes two major segments: alcoholic beverages and fast-moving consumer goods, and health products. The change in performance is mainly due to factors such as the overall poor operating conditions of the industry, shrinking consumer market, and the deep adjustment period of the baijiu industry, which have led to sales pressure and performance falling short of expectations.
Qinghai Spring Medicinal Resources Technology Co LtdCompany expects net loss due to shrinking consumer market and poor industry conditions, leading to sales pressure.